The plan sets out a new a new recruitment, retention and support package

NICE is not recommending NHS funding for Kyowa Kirin’s Poteligeo (mogamulizumab) as a treatment for mycosis fungoides or […]

Sales decline in the second quarter reflects expected disruption from COVID-19

The monoclonal antibody is the first potential passive immunisation for infants to demonstrate sustained protection across the entire […]

The scientists who developed the first 3D multicellular brain organoid with a functional blood brain barrier now report […]

A technique that maps a patient’s language centers before going into surgery works best when their brain tumor […]

Updated Date: Wed, 22 Jul 2020 00:00:00 EDT

Updated Date: Wed, 22 Jul 2020 00:00:00 EDT

Updated Date: Wed, 22 Jul 2020 00:00:00 EDT

Updated Date: Wed, 22 Jul 2020 00:00:00 EDT